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ABSTRACT 
Vitamin D deficiency is reported as a public health issue, with reports of increased vitamin D 
testing and supplementation globally. Vitamin D deficiency has been linked to most chronic 
diseases including chronic pain. However, its pathophysiology is not fully understood. 
Identifying factors associated with risk of vitamin D deficiency in individuals with chronic pain 
will help minimize time and cost. In this study we aim to examine the factors associated with 
vitamin D testing, intake and doctor advised supplementation in individuals with chronic pain. 
Using a cross-sectional study design, data was collected from 465 individuals with chronic 
pain. This data was analyzed using penalized logistic regression with the least absolute 
shrinkage and selection operator (LASSO) technique. Fifty-seven percent of the participants  
reported been tested for vitamin D, about 40% reported been diagnosed with vitamin D 
deficiency, and of those who had been tested, 60%, reported taking vitamin D supplementation. 
The findings show that older age and higher mean pain intensity score increased an individual's 
chance of being vitamin D deficient. Unemployment or on leave due to pain, part-time 
employment, and being resident of Australia increased chances of being tested for vitamin D. 
While, diagnosed vitamin D deficiency and unemployment or on leave due to pain and in part-
time employment were associated with doctor advised vitamin D supplementation. Identifying 
pre-test risk factors in those with chronic pain will assist doctors and patients alike, in 
identifying who is at risk of vitamin D deficiency, whom to test and treat.  
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INTRODUCTION 
 
Vitamin D is unique among vitamins as it is the only one that the human body can manufacture 
on its own with adequate exposure of the skin to sun (UVB rays) (Lips, 2006). Other vitamins 
need to be ingested via foods, for example vitamin C from fruits and vegetables. On synthesis 
in the skin it undergoes conversion into an “active form” known as 1,25-dihydroxyvitamin D 
which reaches target tissues (Lips, 2006; Norman et al., 1992). For many years vitamin D was 
known as an essential compound for strong bone and skeletal system. Promoting bone 
remodeling and maintaining calcium homeostasis (Norman et al., 1992) was believed to be its 
sole function in the human body. The detection of vitamin D receptors on almost every cell and 
tissue guided the discovery of various genomic and non-genomic functions of vitamin D 
(Trochoutsou, 2015; Verstuyf, 2010). This also established the role of vitamin D in various 
chronic conditions including chronic pain.  
Vitamin D deficiency is reported as a major public health problem worldwide (Holick, 2008; 
Palacios, 2014) with reports of increased vitamin D testing globally (Bilinski, 2012; 
Mittelstaedt, 2010; Satter, 2012). In Australia, the Medicare Benefits Schedule expenditure on 
vitamin D testing was reported to be approximately $143.1 million in the year 2013-2014 
(Bilinski, 2012). Similar figures are reported in Ontario, Canada (Mittelstaedt, 2010) and the 
UK (Satter, 2012). Not surprisingly, a large increase in vitamin D supplementation has also 
been reported (Eysenbach, 2004; Cochran, 2007). 
Vitamin D deficiency has been linked to chronic pain (Huang, 2013; Turner, 2008; Plotnikoff, 
2003) which is the most burdensome non-fatal health condition in terms of years lived with 
disability (Vos et al., 2012) and the third most common health complaint presenting to 
Australian general practitioners (National Pain Strategy, 2010). We undertook a cross-sectional 
survey of patients with chronic pain to examine the factors associated with vitamin D 
deficiency, testing and supplementation. It is anticipated that the findings from this study will 
be beneficial for patients with chronic pain and physicians to guide who may be at risk of 




The study protocol was published prior to analysis (Gaikwad, 2016). The cross-sectional study 
was an online survey of individuals aged 18 years and above who had experienced pain for 
more than 3 months with no restrictions on gender, ethnicity, or country of residence. The 
primary aim of the survey was to investigate the perceptions, beliefs and expectations of 
individuals who experience chronic pain on a daily basis, and the strategies used by them to 
help manage this pain. All participants gave electronic consent prior to beginning the survey.  
Ethical Statement 
The cross-sectional survey was approved by the Human Research Ethics Committee of the 
University of Adelaide (approval no- HREC-2016-0712) and the University of South Australia 
(application id- 0000035791).   
Survey Questionnaire 
A specialized questionnaire was built in accordance with the Checklist for Reporting Results 
of Internet E-Surveys (CHERRIES) (Eysenbach, 2004). The final questionnaire was developed 
using information from a review of the literature that identified potential factors associated 
with vitamin D deficiency. The draft questionnaire was reviewed by two general practitioners, 
piloted, and subsequently adjusted on the basis of their feedback. The survey was also piloted 
on three individuals diagnosed with chronic painful conditions to determine whether questions 
were easily understood and interpreted in the way intended by the researcher. The primary 
change following their feedback was simplifying some of the technical terms used in health 
research and making it more generalized to appeal a wider audience. Face and content validity 
was achieved by consensus among researchers conducting the survey. 
Sample size 
Sample size calculations for estimation were based on how wide a confidence interval we 
considered appropriate. This estimation depended on three parameters, the variance or spread 







Where n= sample size, P = estimated population proportion, δ = precision of the estimate. 
As the estimated population proportion (P), was unknown we set P = 0.5 and δ, was set as 0.05 
with the probability of type-I error being α=0.05.  Using, this formula a sample size of 384 was 
estimated for effect size of 0.5 with 95% CI. 
Statistical Analysis 
To study the best predictors of described outcomes a common practice is to use a statistical 
model depending on the type of the variable (for example a linear model if the outcome is 
continuous). For binary outcomes univariate or multivariate logistic regression is used for 
estimating odds ratio (Lemeshow, 2013). The multivariate logistic regression allows 
simultaneous identification of possible risk factors in one model, after adjusting for all 
predictors. Regular logistic regression estimation is carried out by maximizing the likelihood 
function. However, when we have many potential predictors and the sample size is small, then 
there may not be a meaningful way to estimate the coefficients. In order to overcome this, the 
usual practice is to use stepwise regression. The trouble with stepwise regression is that it uses 
unconstrained least-square estimation processes, which can either over or underestimate effect 
sizes. To solve this issue, we used LASSO (Least absolute shrinkage and selection operator). 
LASSO is a regression technique that allows the selection of variables and estimation 
simultaneously in order to enhance the accuracy of the prediction and its interpretability 
(Tibshirani, 1996). LASSO was initially designed for simple linear regression, but was 
extended for general linear models such as logistic regression (Harrell, 1998). Estimation in 
LASSO is based on penalizing the likelihood  
𝛽(𝜆) ̂ = argmax
𝛽





where 𝛽, is the effect size estimate using maximum likelihood, 𝜆  is the penalty parameter and 
p is the number of covariates in the model. The parameter 𝜆  controls the complexity of the 
model. In cases where 𝜆 is zero, the estimate will be same as the simple logistic regression. To 
obtain an optimal value of the penalty parameter we looked at the convergence of the 
likelihood. For some of the models the penalty value was 0.5, and for others the penalty was 2. 
The other benefit of using LASSO is it actually specifies the covariates whose effect sizes are 
exactly zero, thus allowing selection of variables. All the statistical analysis was done in 
STATA 14.1. The LASSO logits regression were fitted using a special user written program in 
STATA [http://www.homepages.ucl.ac.uk/~ucakgam/stata.html]. 
Outcome measures  
The outcomes were related to patient reported testing, prescription and consumption of vitamin 
D supplements. The following information was collected from the participants: i) had they been 
tested for vitamin D levels; ii) were their test results for vitamin D reported as deficient; iii) 
which supplements they used for their pain and for other ailments; and iv) which of those 
supplements were advised by their doctor. All outcome responses are dichotomized and were 
coded as 1 if Yes and 0 if No. 
Independent Variables 
The independent variables were the demographic factors of the participants’ which included 
age, gender, country of residence, marital status, education level and employment status. 
Information regarding participants’ pain experience was also collected. Participants were asked 
‘which of the following describe the characteristics of your pain? The choices given were 
aching, burning, sharp, pins and needles, throbbing and others. Participants were also asked if 
their pain was triggered by an injury, options provided were Yes and No. Participants also 
completed a numerical rating scale (NRS) anchored at left with 0 = no pain and at right with 
10 = severe/worst pain in answer to the question ‘what’s the average severity of your pain?’  
RESULTS 
The survey was conducted online from 29th August to 24th October 2016.  573 people in total 
participated however, 108 of these had incomplete information and hence were excluded from 
the analysis thus giving us a complete sample of 465 participants. All analyses were conducted 
presuming no participants completed the survey multiple times.  Distributions of the 
demographic characteristics of 465 participants are presented in Table 1. 
Table 1 Distribution of the demographic characteristics of the sample  
The age of participants ranged from 18 to 90 years, with almost equal number of participants 
from the age groups between 31- 40 years (22%) and 41-50 years (22%). Most participants 
were female and about two thirds were from Australia. Among the 465 participants, 57% 
(n=267 /465) reported that they had been tested for vitamin D and about 40% were aware that 
they had been diagnosed with vitamin D deficiency. Of those who had been tested for vitamin 
D, 60% (n= 162/267) were in fact taking vitamin D supplementation. 
To identify significant predictors of each outcome a simple logistic regression analysis was 
performed. In each of these, individual logistic regressions all the factors presumed to be 
clinically useful for predicting the outcome, were entered simultaneously. In the simple logistic 
regression, the factors significant for vitamin D testing were education, country of residence, 
employment status and gender. The factors that were significant for predicting vitamin D 
deficiency were gender and mean pain intensity. The factors significant for vitamin D intake 
were age, gender, employment status, marital status, education and country of residence. All 
these factors that were entered in logistic regressions were re-entered into the LASSO model. 
Results from the penalized logistic regression with LASSO suggest that some of the predictors 
that were initially significant in simple logistic regression were actually not statistically 
significant after penalizing.  
The final model for the prediction of vitamin D deficiency consisted of six predictors: age, 
gender, country of residence, employment status, mean pain intensity and diagnosis for pain 
problem. For vitamin D testing additional predictors considered were: education level, pain 
related to injury, and duration of pain. For, vitamin D intake and doctor advised vitamin D 
supplementation, characteristics of pain, vitamin D deficiency, and vitamin D testing were 
considered.  
The predictors gender (gender 0= females, 1= males), pain related to injury (No= 0, Yes =1), 
mean pain intensity (0 = ≤ 5 or 1= ≥ 6 on 11 point numerical scale), duration of pain (0 = <1 
year or 1 = > 1 year), vitamin D tested (No= 0, Yes =1) and vitamin D deficient (No= 0, Yes 
=1) were treated as binary variables. Due to fewer number of cases in each individual category 
the characteristics of pain were categorized into 3 groups; 0= 1-4 characteristics, 1= 5-8 
characteristics and 2= >9 characteristics, which is used as the base category for LASSO. The 
categorical predictors were re-coded as dummy variables before submitting in the regression.  
Outcomes –  
Table 2 presents a summary of factors associated with vitamin D testing. The odds ratios (OR) 
and their CIs suggest that males are half as likely as females to be tested for vitamin D. 
Similarly, the odds of an individual with chronic pain being tested for vitamin D are 2.3 times 
higher if they were from Australia, and 0.3 times less likely if they were from New Zealand, 
than if they were from other countries. In addition, chronic pain patients who were unemployed 
or on leave due to pain and in part-time employment were twice as likely to be tested for 
vitamin D. Age, education level, pain related to injury, mean pain intensity of pain and duration 
of pain were not associated with vitamin D testing.  
Table 2 Summary of LASSO for factors associated with vitamin D testing 
 
Table 3 presents a summary of factors associated with vitamin D deficiency. The ORs and CIs 
suggest that for individuals with chronic pain the odds of being vitamin D deficient are 
approximately three times higher if they are older than 30 than if they are not. Similarly, the 
individual with chronic pain who has a mean pain intensity ≥6 on an 11 point NRS are twice 
as likely to be vitamin D deficient then an individual with chronic pain who has a mean pain 
intensity ≤5. Gender, country of residence and employment status were not associated with 
patient reported vitamin D deficiency.  
Table 3 Summary of LASSO for factors associated with vitamin D deficiency 
Table 4 presents a summary of factors associated with taking vitamin D supplements. The ORs 
and CIs suggest that individuals with chronic pain aged between 51-60 years are three times 
more likely to be taking vitamin D supplements than those aged 50 years or younger, and those 
older than 60 are six times more likely. Not surprisingly, those who had been vitamin D 
deficient were six times more likely to take vitamin D supplements than those who were not. 
Gender, country of residence, education level, mean pain intensity, characteristics of pain, 
duration of pain, pain related to injury and tested for vitamin D were not associated with 
vitamin D supplement intake.   
Table 4 Summary of LASSO for factors associated with intake of vitamin D supplement 
Table 5 presents a summary of factors associated with doctor advised vitamin D 
supplementation. Individuals with chronic pain who were unemployed or on leave due to pain 
and in part-time employment were 4 times more likely than full-time employed participants to 
be prescribed vitamin D supplements by their doctor. Not surprisingly, being vitamin D 
deficient had the largest influence on whether doctors would prescribe vitamin D. Age, gender, 
country of residence, education level, mean pain intensity, duration of pain and whether pain 
related to injury were not associated with being prescribed vitamin D supplement.  Finally, and 
surprisingly, whether or not someone had been tested for vitamin D levels was not associated 
with being prescribed vitamin D supplement. 




Data from this cross-sectional survey suggests that gender, country of residence and 
employment status were associated with being tested for vitamin D. Australians were much 
more likely to be tested for vitamin D than other nationalities. These findings resonate with 
reports that demonstrate rise in vitamin D testing globally (Australian Governmnet MBS 
review, 2014; Epling, 2014) and a remarkable 3587% rise in vitamin D testing in Australia 
over last 10 years (Epling, 2014).  
Older people and individuals who reported a mean pain intensity score ≥ 6 on an 11 point NRS 
were more likely to report vitamin D deficiency. To our knowledge, this is the first time that 
intensity of self-reported pain has been identified as being associated with vitamin D 
deficiency. That older people were more likely to report vitamin D deficiency is in line with 
the association between age and risk of developing vitamin D deficiency (Holick et al., 2011; 
van Schoor, 2011), which has been attributed to insufficient sun exposure time (Brock, 2004) 
and decline in the capacity to synthesize vitamin D (Durvasula, 2010).  Not surprisingly then, 
along with diagnosis of vitamin D deficiency, age was associated with taking vitamin D 
supplements. Supplement usage in general is reported to increase with age (Bailey, 2013; 
Radimer, 2004; Dickinson, 2014), but not to the levels observed here for vitamin D. Not 
surprisingly, doctors advised vitamin D supplementation to individuals who were vitamin D 
deficient, unemployed or on leave due to chronic pain and in part time employment.  
To the best of our knowledge, most previous studies have investigated vitamin D deficiency 
and insufficiency among healthy populations in Australia (Tran et al., 2013), Europe (Sohl et 
al., 2014) and America (Mitchell 2012). These are findings are important as it highlights factors 
associated with deficiency, testing, intake and doctor advised supplementation of vitamin D in 
patients with chronic pain. 
That vitamin D deficiency has been proposed as a cause of nonspecific muscular and bone pain 
(Lyman, 2005) would predict that pain characteristics, intensity and duration would relate to 
testing, prescribing or taking vitamin D supplementation. We found only a relationship 
between pain intensity and vitamin D deficiency. Our design does not allow causal attribution, 
but it is notable that there are biological pathways that could lead from vitamin D deficiency 
to pain. For example, it is thought that vitamin D deficiency reduces calcium phosphate, which 
then makes the collagen matrix surrounding the bone rubbery. This can cause pressure on the 
periosteal covering, which is innervated by sensory fibers (Lyman, 2005). Even slight pressure 
on the bone can produce pain. In view of this mechanistic plausibility of vitamin D deficiency 
to modulate pain levels in patients experiencing chronic pain, it is plausible that it could be one 
of the reasons for higher mean pain intensity being reported by patients who were vitamin D 
deficient. Clearly, longitudinal data are required to investigate this possibility. 
Our results have practical implications. Identifying several factors associated with a risk of 
vitamin D deficiency may assist doctors in identifying patients with chronic pain who would 
more likely benefit from vitamin D supplementation for their chronic pain problem. About 25% 
of adults worldwide have persistent pain – to test everyone would be expensive and perhaps of 
limited return. There is clearly merit in identifying pre-test risk factors in those with chronic 
pain, so as to minimize unnecessary testing.  
Study Limitations  
Our adherence to CHERRIES recommendations (Eysenbach, 2004) gives us confidence in 
minimising bias and our online approach allowed us to reach the a priori sample size and 
diversity that was required to fulfil our aims. However, this approach also has clear limitations. 
We relied on word of mouth, social media networks and promotion through consumer 
advocates to recruit our sample, a process that might introduce a bias towards sampling within 
established social media networks and diagnostic groups. That the survey was online clearly 
limits our sample to those with internet connectivity and engagement, and computer skills. We 
were also bound by considerations of participant burden (Groves, 2009), which meant that we 
decided a priori on the basis of pilot testing, to not collect information on participants’ outdoor 
activities, sun exposure time and safe sun practices and the type and dosage of vitamin D 
supplement preferred by the participants.  These data might have offered important insights. 
Finally, any survey is dependent on self-report and little is known about the validity of 
questions such as those asked here when compared to non-self-report assessment approaches.  
 
CONCLUSION 
In summary, the results from the present study examine the associations between vitamin D 
testing, deficiency, intake and doctor advised vitamin D supplementation in individuals with 
chronic pain. The simple demographic and pain-related factors, could be used as a guide to 
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